Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi Schwarzenbach

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
The EPMA Journal|December 4, 2012
Predictive diagnostics in colorectal cancer: impact of genetic polymorphisms on individual outcomes and treatment with fluoropyrimidine-based chemotherapyHeidi Schwarzenbach
Breast Cancer Research : BCR|October 5, 2013
Circulating nucleic acids as biomarkers in breast cancerHeidi Schwarzenbach
Methods in Molecular Biology (Clifton, N.J.)|December 24, 2018
Copy Number Variation Analysis on Cell-Free Serum DNAHeidi Schwarzenbach
Ebiomedicine|November 15, 2016
Biological and Clinical Relevance of H19 in Colorectal Cancer PatientsHeidi Schwarzenbach
Analytical Biochemistry|September 18, 2002
A diagnostic tool for monitoring multidrug resistance expression in human tumor tissuesHeidi Schwarzenbach
Expert Review of Molecular Diagnostics|July 24, 2015
The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancerHeidi Schwarzenbach
Non-Coding RNA|October 25, 2024
Interplay of microRNAs and circRNAs in Epithelial Ovarian CancerHeidi Schwarzenbach
Oncology Research and Treatment|July 7, 2017
Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer PatientsHeidi Schwarzenbach
Drug Testing and Analysis|June 15, 2011
Impact of physical activity and doping on epigenetic gene regulationHeidi Schwarzenbach
Medical Oncology (Northwood, London, England)|August 16, 2002
Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myelomaHeidi Schwarzenbach
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
The EPMA Journal|December 4, 2012
Predictive diagnostics in colorectal cancer: impact of genetic polymorphisms on individual outcomes and treatment with fluoropyrimidine-based chemotherapyHeidi Schwarzenbach
Breast Cancer Research : BCR|October 5, 2013
Circulating nucleic acids as biomarkers in breast cancerHeidi Schwarzenbach
Methods in Molecular Biology (Clifton, N.J.)|December 24, 2018
Copy Number Variation Analysis on Cell-Free Serum DNAHeidi Schwarzenbach
Ebiomedicine|November 15, 2016
Biological and Clinical Relevance of H19 in Colorectal Cancer PatientsHeidi Schwarzenbach
Analytical Biochemistry|September 18, 2002
A diagnostic tool for monitoring multidrug resistance expression in human tumor tissuesHeidi Schwarzenbach
Expert Review of Molecular Diagnostics|July 24, 2015
The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancerHeidi Schwarzenbach
Non-Coding RNA|October 25, 2024
Interplay of microRNAs and circRNAs in Epithelial Ovarian CancerHeidi Schwarzenbach
Oncology Research and Treatment|July 7, 2017
Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer PatientsHeidi Schwarzenbach
Drug Testing and Analysis|June 15, 2011
Impact of physical activity and doping on epigenetic gene regulationHeidi Schwarzenbach
Medical Oncology (Northwood, London, England)|August 16, 2002
Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myelomaHeidi Schwarzenbach
Pageof 10